Medical devices, healthcare technology and the business of care
PMA approval · P860057

EDWARDS LIFESCIENCES PERIMOUNT AORTIC AND MITRAL BIOPROSTHESES

Edwards Lifesciences, LLC · Decision date Sep 26, 1991

MEDTECHLEDGER EXPLANATIONP860057

What did the FDA approve?

This FDA database entry records an original PMA approval for the Carpentier-Edwards Pericardial Bioprosthesis, Model 2700, granted to Edwards Lifesciences, LLC on September 26, 1991. The decision field is labeled APPR, and the statement identifies the approved device as a replacement heart-valve under product code DYE in the cardiovascular specialty.

The source statement describes the device's intended use as replacing a natural aortic valve when aortic valvular disease is sufficiently advanced, and as replacing a previously implanted aortic valve prosthesis that is no longer functioning adequately. The entry does not include supplement type, supplement reason, or any independent safety or effectiveness data. The statement's reported purpose is distinct from proof of clinical performance.

FDA approval order statement

Approval for the Carpentier-Edwards Pericardial Bioprosthesis, Model 2700. This device is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Sep 26, 1991

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P860057
Regulatory pathway
Premarket approval application
Product code
DYE
Decision code
APPR
Decision date
Sep 26, 1991
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: replacement Heart-valve.

Product code
DYE
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P860057 received

    Application receipt date recorded by FDA.

  2. P860057 · FDA decision

    APPR

  3. P860057/S228 · Related supplement

    Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process (2800TFX), Carpen

Timeline entries are records held by MedtechLedger for P860057. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P860057

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records